Metformin Attenuates Renal Interstitial Fibrosis Through Upregulation of Deptor in Unilateral Ureteral Obstruction in Rats

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2020 Sep 16

PMID 32934682

Citations 5

Authors

Yanxia Wang

Yan Wang

Yong Li

Linghong Lu

Yingxian Peng

Shu Zhang

Anzhou Xia

Affiliations

Soon will be listed here.

Abstract

Renal interstitial fibrosis (RIF) is a common pathological process that accompanies chronic kidney disease (CKD) and that progresses to end-stage renal failure (ESRD). Accumulating evidence has revealed that persistent mammalian target of rapamycin (mTOR) activation in kidneys is closely associated with the occurrence and progression of CKD. The DEP domain-containing mTOR interacting protein (Deptor) is an endogenous negative regulator of mTOR. Metformin can attenuate renal fibrosis in an animal model of diabetic nephropathy. Previous studies demonstrated that metformin can attenuate renal fibrosis in several models of CKD. However, the precise mechanisms of this effect are not well understood. The present study aimed to examine the mechanism of action of metformin on unilateral ureteral obstruction (UUO)-induced RIF in rats Sprague-Dawley rats were randomly divided into a sham-operated group, three UUO groups examined at different time points (3, 7 and 14 days after UUO surgery), and three metformin-treated groups, treated with three different concentrations of metformin. The metformin-treated groups were administered metformin orally every day for 14 consecutive days following surgery. The protein expression levels of Deptor, α-smooth muscle actin (α-SMA), phosphorylated (p-)mTOR, p-ribosomal protein S6 kinase (p-p70S6K) and CD68 were assessed. The present results suggested that, following UUO, there was a significant reduction of Deptor expression, and an increase in collagen deposition in the extracellular matrix over time, accompanied by an increased expression of several proteins including CD68, α-SMA, p-mTOR and p-p70S6K. Notably, metformin treatment reversed these effects. In conclusion, the present results suggested that metformin attenuated RIF of UUO rats, and the mechanism of action was found to be associated with the increase in Deptor expression and inhibition of the mTOR/p70S6K pathway in the kidneys of UUO rats.

Citing Articles

Interrelation of Natural Polyphenol and Fibrosis in Diabetic Nephropathy.

Ma Y, Wang J, Fan J, Jia H, Li J Molecules. 2025; 30(1).

PMID: 39795078 PMC: 11722366. DOI: 10.3390/molecules30010020.

Synergistic modulation of endoplasmic reticulum stress pathway, oxidative DNA damage and apoptosis by β-amyrin and metformin in mitigating hyperglycemia-induced renal damage using adult zebrafish model.

Roohi T, Krishna K, Shakeel F BMC Pharmacol Toxicol. 2024; 25(1):66.

PMID: 39334288 PMC: 11430224. DOI: 10.1186/s40360-024-00797-9.

Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis.

Barsotti G, Luciano R, Kumar A, Meliambro K, Kakade V, Tokita J Kidney Int Rep. 2024; 9(5):1354-1368.

PMID: 38707807 PMC: 11068976. DOI: 10.1016/j.ekir.2024.02.006.

Metformin inhibits EV71‑induced pyroptosis by upregulating DEP domain‑containing mTOR‑interacting protein.

Zhang X, Sun C, Hao J, Cao L, Zhang X, Du J Exp Ther Med. 2023; 26(2):388.

PMID: 37456175 PMC: 10347180. DOI: 10.3892/etm.2023.12087.

Metformin and Glaucoma-Review of Anti-Fibrotic Processes and Bioenergetics.

Hurley D, Irnaten M, OBrien C Cells. 2021; 10(8).

PMID: 34440899 PMC: 8394782. DOI: 10.3390/cells10082131.

References

Brynildsen J, Lee B, Perron I, Jin S, Kim S, Blendy J . Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal. Proc Natl Acad Sci U S A. 2018; 115(16):4282-4287. PMC: 5910809. DOI: 10.1073/pnas.1707047115. View

Bruneau S, Nakayama H, Woda C, Flynn E, Briscoe D . DEPTOR regulates vascular endothelial cell activation and proinflammatory and angiogenic responses. Blood. 2013; 122(10):1833-42. PMC: 3765062. DOI: 10.1182/blood-2013-03-488486. View

Maity S, Bera A, Ghosh-Choudhury N, Das F, Kasinath B, Ghosh Choudhury G . microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression. Exp Cell Res. 2018; 364(1):5-15. PMC: 5825286. DOI: 10.1016/j.yexcr.2018.01.021. View

Zhou X, Muise E, Haimbach R, Sebhat I, Zhu Y, Liu F . PAN-AMPK Activation Improves Renal Function in a Rat Model of Progressive Diabetic Nephropathy. J Pharmacol Exp Ther. 2019; 371(1):45-55. DOI: 10.1124/jpet.119.258244. View

Kita Y, Takamura T, Misu H, Ota T, Kurita S, Takeshita Y . Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. PLoS One. 2012; 7(9):e43056. PMC: 3445596. DOI: 10.1371/journal.pone.0043056. View

Wu M, Wen M, Chiu Y, Chiou Y, Shu K, Tang M . Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int. 2006; 69(11):2029-36. DOI: 10.1038/sj.ki.5000161. View

Aboudehen K, Farahani S, Kanchwala M, Chan S, Avdulov S, Mickelson A . Long noncoding RNA is dysregulated in autosomal dominant polycystic kidney disease and regulates mTOR signaling. J Biol Chem. 2018; 293(24):9388-9398. PMC: 6005429. DOI: 10.1074/jbc.RA118.001723. View

Caron A, Baraboi E, Laplante M, Richard D . DEP domain-containing mTOR-interacting protein in the rat brain: distribution of expression and potential implication. J Comp Neurol. 2014; 523(1):93-107. DOI: 10.1002/cne.23668. View

Kim D, Cheng G, Lindsley C, Yang H, Cheng J . Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer. Curr Opin Investig Drugs. 2005; 6(12):1250-8. View

10.

Guiteras R, Flaquer M, Cruzado J . Macrophage in chronic kidney disease. Clin Kidney J. 2016; 9(6):765-771. PMC: 5162417. DOI: 10.1093/ckj/sfw096. View

11.

Meng X, Wang S, Huang X, Yang C, Xiao J, Zhang Y . Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis. Cell Death Dis. 2016; 7(12):e2495. PMC: 5261004. DOI: 10.1038/cddis.2016.402. View

12.

Das F, Bera A, Ghosh-Choudhury N, Abboud H, Kasinath B, Ghosh Choudhury G . TGFβ-induced deptor suppression recruits mTORC1 and not mTORC2 to enhance collagen I (α2) gene expression. PLoS One. 2014; 9(10):e109608. PMC: 4198127. DOI: 10.1371/journal.pone.0109608. View

13.

Chen Y, Kong L, Tang Z, Zhang Y, Liu Y, Wang T . Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ARE/glyoxalase 1 pathway. Biomed Pharmacother. 2019; 111:1166-1175. DOI: 10.1016/j.biopha.2019.01.030. View

14.

Obara A, Fujita Y, Abudukadier A, Fukushima T, Oguri Y, Ogura M . DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells. Biochem Biophys Res Commun. 2015; 460(4):1047-52. DOI: 10.1016/j.bbrc.2015.03.148. View

15.

Kapoor V, Zaharieva M, Das S, Berger M . Erufosine simultaneously induces apoptosis and autophagy by modulating the Akt-mTOR signaling pathway in oral squamous cell carcinoma. Cancer Lett. 2011; 319(1):39-48. DOI: 10.1016/j.canlet.2011.12.032. View

16.

Montinaro V, Hevey K, Aventaggiato L, Fadden K, Esparza A, Chen A . Extrarenal cytokines modulate the glomerular response to IgA immune complexes. Kidney Int. 1992; 42(2):341-53. DOI: 10.1038/ki.1992.295. View

17.

Krause U, Bertrand L, Hue L . Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. Eur J Biochem. 2002; 269(15):3751-9. DOI: 10.1046/j.1432-1033.2002.03074.x. View

18.

Wang C, Dai H, Xiong Z, Song Q, Zou Z, Li M . Loss of DEPTOR in renal tubules protects against cisplatin-induced acute kidney injury. Cell Death Dis. 2018; 9(5):441. PMC: 5906659. DOI: 10.1038/s41419-018-0483-3. View

19.

Raman A, Parnell S, Zhang Y, Reif G, Dai Y, Khanna A . Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease. Am J Physiol Renal Physiol. 2018; 315(6):F1695-F1707. PMC: 6336984. DOI: 10.1152/ajprenal.00246.2018. View

20.

Das F, Ghosh-Choudhury N, Bera A, Dey N, Abboud H, Kasinath B . Transforming growth factor β integrates Smad 3 to mechanistic target of rapamycin complexes to arrest deptor abundance for glomerular mesangial cell hypertrophy. J Biol Chem. 2013; 288(11):7756-7768. PMC: 3597815. DOI: 10.1074/jbc.M113.455782. View